Which closed-end funds own Apogee Therapeutics Inc?
3 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $12.7M. Security type: common equity. Country: United States. CUSIP 03770N101 · ISIN US03770N1019 · ticker APGE.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GDL GDL Fund | U.S. Equity | 1.71% | $2.1M | 15,800 sh | $122M | 21.5% discount | Jun 30, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 0.69% | $7.5M | 56,391 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.54% | $3.1M | 23,470 sh | $573M | 3.7% discount | Jun 30, 2026 |
3 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: APOGEE THERAPEUTICS INC.
Issuer-level search for “APGE” → · Compare two funds’ portfolios →